Subtype
Testicular Neoplasm
CI-CAN-00004087Explore in graph →
Non-malignant50 active trials3 approved drugs
Loading cancer entity…
Subtype
CI-CAN-00004087Explore in graph →
Clinical trials
286 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01242072 | Intravenous Palifosfamide-tris in Combination With Etoposide and Carboplatin in Patients With Malignancies | completed | Phase 1 | 22 | Alaunos TherapeuticsINDUSTRY | 1 | Sep 29, 2026 | clinicaltrials |
| NCT07841041 | Effects of Testicular Self-Examination Training Methods on Students' Behaviors and Health Beliefs | completed | N/A | 122 | Yeditepe UniversityOTHER | 1 | Sep 25, 2026 | clinicaltrials |
| NCT00034424 |
| Cause of Familial Testicular Cancer |
| completed |
| — |
| 749 |
| National Cancer Institute (NCI)NIH |
| 1 |
| Sep 22, 2026 |
| clinicaltrials |
| NCT00183820 | Study of Gemcitabine, Oxaliplatin, and Paclitaxel in Patients With Refractory Germ Cell Carcinoma | completed | Phase 2 | 30 | University of Southern CaliforniaOTHER | 1 | Jul 1, 2026 | clinicaltrials |
| NCT02883049 | Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive Mutations | completed | Phase 3 | 5,949 | National Cancer Institute (NCI)NIH | 7 | Jun 2, 2026 | clinicaltrials |
| NCT07615998 | Young Adult Latino Testicular Cancer Survivors: a Pilot Study of Goal-Focused Emotion Regulation Therapy (GET) | completed | N/A | 35 | University of California, IrvineOTHER | 1 | May 29, 2026 | clinicaltrials |
| NCT02433197 | Effectiveness of an Individualized Program of Muscular Strength and Endurance Program for Improving Germ Cell Cancer(EFICATEST) | completed | N/A | 20 | University of MalagaOTHER | 1 | Apr 8, 2026 | clinicaltrials |
| NCT02213913 | Lenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell Lymphomas | completed | Phase 1 / Phase 2 | 55 | University of ChicagoOTHER | 1 | Mar 11, 2026 | clinicaltrials |
| NCT06582849 | Enhanced Assistance During Radiotherapy for Unmet Essential Needs(EARN) | completed | N/A | 33 | Washington University School of MedicineOTHER | 1 | Aug 26, 2025 | clinicaltrials |
| NCT03426865 | Role of Axumin PET Scan in Germ Cell Tumor(TESTPET) | completed | — | 10 | University of Texas Southwestern Medical CenterOTHER | 1 | Aug 11, 2025 | clinicaltrials |
| NCT04531709 | Financial Toxicity and Quality of Life in Patients With TGCT | completed | — | 24 | The University of Texas Health Science Center at San AntonioOTHER | 1 | Jul 14, 2025 | clinicaltrials |
| NCT06964841 | PRIMARY TESTICULAR LYMPHOMA | completed | — | 1 | Instituto Mexicano del Seguro SocialOTHER_GOV | 1 | May 9, 2025 | clinicaltrials |
| NCT00638898 | Busulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagnosed or Relapsed Solid Tumor | completed | Phase 1 | 25 | City of Hope Medical CenterOTHER | 1 | Mar 20, 2025 | clinicaltrials |
| NCT06318182 | Testicular Self-Examination Awareness in Young Men | completed | N/A | 120 | Hitit UniversityOTHER | 1 | Mar 14, 2025 | clinicaltrials |
| NCT00104676 | Combination Chemotherapy in Treating Patients With Stage II or Stage III Germ Cell Tumors | completed | Phase 3 | 263 | UNICANCEROTHER | 3 | Feb 6, 2025 | clinicaltrials |
| NCT04028479 | The Registry of Oncology Outcomes Associated With Testing and Treatment(ROOT) | completed | — | 167 | Taproot HealthINDUSTRY | 1 | Dec 18, 2024 | clinicaltrials |
| NCT01726374 | Trial of 1 Cycle of Adjuvant BEP Chemotherapy in High Risk, Stage 1 Non-seminomatous Germ Cell Testis Tumours(111) | completed | Phase 3 | 246 | Institute of Cancer Research, United KingdomOTHER | 1 | Dec 4, 2024 | clinicaltrials |
| NCT00936936 | High-dose Chemotherapy for Poor-Prognosis Relapsed Germ-Cell Tumors | completed | Phase 2 | 64 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 26, 2024 | clinicaltrials |
| NCT03339635 | Short-term Testosterone Replacement in Testicular Cancer Survivors | completed | Phase 2 | 32 | University Medical Center GroningenOTHER | 1 | Jul 30, 2024 | clinicaltrials |
| NCT02573584 | Vascular Fingerprint Validation Study | completed | — | 101 | University Medical Center GroningenOTHER | 3 | May 17, 2024 | clinicaltrials |
| NCT02602041 | Knowledge and Attitudes Regarding Healthy Lifestyle and Health Behavior Change in Cancer Patients and Their Partners; A Pilot Study | completed | — | 38 | University Medical Center GroningenOTHER | 1 | May 6, 2024 | clinicaltrials |
| NCT00161174 | Cardiovascular Morbidity in Testicular Cancer Survivors: Study of Risk Factors and Assessment of Pharmacogenomic Determinants of Toxicity | completed | — | 173 | University Medical Center GroningenOTHER | 1 | May 3, 2024 | clinicaltrials |
| NCT01641172 | Taste, Smell and Chemotherapy (TASTY)(TASTY) | completed | Phase 4 | 140 | University Medical Center GroningenOTHER | 1 | Apr 19, 2024 | clinicaltrials |
| NCT06309732 | GAMEC-II, Risk-adapted Protocol for Relapsed Germ Cell Tumours (GCT)(GAMEC-II) | completed | Phase 2 | 36 | Queen Mary University of LondonOTHER | 1 | Mar 13, 2024 | clinicaltrials |
| NCT06044220 | Testicular Self-examination Training Given to Students | completed | N/A | 100 | Karabuk UniversityOTHER | 1 | Sep 25, 2023 | clinicaltrials |
| NCT00003518 | Paclitaxel Plus Gemcitabine in Treating Patients With Refractory Metastatic Germ Cell Tumors | completed | Phase 2 | 44 | Eastern Cooperative Oncology GroupNETWORK | 2 | Jun 22, 2023 | clinicaltrials |
| NCT00003800 | Diagnostic Study of Patients With Stage I Testicular Cancer | completed | N/A | 76 | Eastern Cooperative Oncology GroupNETWORK | 1 | Jun 22, 2023 | clinicaltrials |
| NCT01684098 | Safety and Efficacy of FalateScan (Technetium Tc 99m EC20) in Patients With Known Suspected Recurrent or Metastatic Cancer From a Solid Tumor | completed | Phase 2 | 40 | EndocyteINDUSTRY | 0 | Jun 22, 2023 | clinicaltrials |
| NCT00002520 | Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer | completed | N/A | 434 | Eastern Cooperative Oncology GroupNETWORK | 1 | Jun 15, 2023 | clinicaltrials |
| NCT04180033 | Diagnostic Yield of Colonoscopy Surveillance in Testicular Cancer Survivors Treated With Platinum-based Chemotherapy(CATCHER) | completed | N/A | 154 | The Netherlands Cancer InstituteOTHER | 1 | Jan 31, 2023 | clinicaltrials |
| NCT02643303 | A Study of Tremelimumab and IV Durvalumab Plus Poly-ICLC in Subjects With Biopsy-accessible Cancers | completed | Phase 1 / Phase 2 | 58 | Ludwig Institute for Cancer ResearchOTHER | 1 | Dec 2, 2022 | clinicaltrials |
| NCT05056688 | Effect of Online Education Given to Young Adults on Testicular Cancer Health Beliefs and Behaviors | completed | N/A | 90 | Agri Ibrahim Cecen UniversityOTHER | 1 | Oct 10, 2022 | clinicaltrials |
| NCT04935255 | Determining the Clinical Relevance of the inTeraction Between AprepitaNt aNd EtoposiDe(TANNED) | completed | — | 17 | Radboud University Medical CenterOTHER | 1 | Sep 10, 2022 | clinicaltrials |
| NCT05083143 | The Impact of the COVID-19 Pandemic on Testicular Cancer | completed | — | 50 | Ankara Training and Research HospitalOTHER | 1 | Apr 27, 2022 | clinicaltrials |
| NCT03436901 | Whole Body MRI With DWI for Monitoring Patients Treated for Testicular Cancer Stage II-III(TENY) | completed | N/A | 90 | Aarhus University HospitalOTHER | 1 | Jan 3, 2022 | clinicaltrials |
| NCT05073198 | The Effect of the Brochure on Testicular Self-Exam | completed | N/A | 92 | Selcuk UniversityOTHER | 1 | Oct 11, 2021 | clinicaltrials |
| NCT00053352 | Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors | completed | Phase 3 | 302 | Children's Oncology GroupNETWORK | 6 | Jul 13, 2021 | clinicaltrials |
| NCT00536601 | High-Dose Chemotherapy With or Without Total-Body Irradiation Followed by Autologous Stem Cell Transplant in Treating Patients With Hematologic Cancer or Solid Tumors | completed | N/A | 174 | Roswell Park Cancer InstituteOTHER | 1 | Apr 22, 2021 | clinicaltrials |
| NCT01037790 | Phase II Trial of the Cyclin-Dependent Kinase Inhibitor PD 0332991 in Patients With Cancer | completed | Phase 2 | 304 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Mar 11, 2021 | clinicaltrials |
| NCT02860819 | Study of Gemcitabine, Carboplatin and VELIPARIB (ABT-888) in Refractory Testicular Germ Cell Cancer | completed | Phase 2 | 15 | National Cancer Institute, SlovakiaOTHER_GOV | 1 | Mar 3, 2021 | clinicaltrials |
| NCT00002566 | Combination Chemotherapy With Bone Marrow Transplantation in Treating Men With Germ Cell Tumors | completed | Phase 3 | 280 | UNICANCEROTHER | 1 | Feb 23, 2021 | clinicaltrials |
| NCT01258998 | Study of Akt Inhibitor MK2206 in Patients With Relapsed Lymphoma | completed | Phase 2 | 60 | National Cancer Institute (NCI)NIH | 1 | Nov 4, 2020 | clinicaltrials |
| NCT04122430 | Risk of Venous Thromboembolism in Patients Receiving First-Line Chemotherapy for Disseminated Germ Cell Tumours(G3 RPLN PBC) | completed | — | 1,135 | Walter and Eliza Hall Institute of Medical ResearchOTHER | 1 | Oct 19, 2020 | clinicaltrials |
| NCT02429466 | Study of the Hypomethylating Drug Guadecitabine (SGI-110) Plus Cisplatin in Relapsed Refractory Germ Cell Tumors | completed | Phase 1 | 14 | Nasser HannaOTHER | 1 | Sep 23, 2020 | clinicaltrials |
| NCT02677727 | Study of Cisplatin-Induced Peripheral Neuropathy in Patients With Germ Cell Tumor | completed | — | 54 | Costantine AlbanyOTHER | 1 | Sep 22, 2020 | clinicaltrials |
| NCT00341588 | A Case-Control Study of Testicular Germ Cell Tumors Among U.S. Military Servicemen | completed | — | 2,772 | National Cancer Institute (NCI)NIH | 1 | Aug 21, 2020 | clinicaltrials |
| NCT00342537 | Genetics of Familial Testicular Cancer | completed | — | 1,842 | National Cancer Institute (NCI)NIH | 1 | Jul 17, 2020 | clinicaltrials |
| NCT02743481 | Early Life Exposures in Agriculture | completed | — | 60,000 | National Cancer Institute (NCI)NIH | 1 | Apr 20, 2020 | clinicaltrials |
| NCT02890030 | The Platinum Study Comparison Group | completed | — | 102 | Lawrence EinhornOTHER | 1 | Apr 8, 2020 | clinicaltrials |
| NCT02991209 | Study of Testosterone vs Placebo in Testicular Cancer Survivors(Einstein) | completed | Phase 2 / Phase 3 | 69 | Mikkel BandakOTHER | 1 | Mar 6, 2020 | clinicaltrials |
Data updated 20 hours agoSource updated Sep 29, 2026source: clinicaltrials